Guardion Health Sciences, Inc. (NasdaqCM:GHSI) announced that it engaged ROTH Capital Partners, LLC as its financial advisor to conduct a strategic review process focused on maximizing stockholder value. The company's management team and Board of Directors believe that the current market valuation of the Company does not accurately reflect the potential value of the Company and the clinical nutrition platform that the company is building. The Company is therefore exploring a diverse range of strategic options to help grow the Company and enhance stockholder value, including, among other things, a sale, merger, acquisitions, reverse acquisition, or other strategic transaction.

There can be no assurances, however, that this process will result in a transaction, or that if a transaction is completed, it will ultimately enhance stockholder value. There is no set timetable for the strategic review process and the Company does not intend to provide periodic updates until the Board of Directors makes a formal decision and determines that disclosure is appropriate and/or necessary under the circumstances.